Related Experiment Videos
Intermediate metabolism in Trypanosoma cruzi
1Instituto de Investigaciones Bioquímicas Lus F. Leloir. Fundación Campomar, CONICET, Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires, Argentina.
Journal of Bioenergetics and Biomembranes
|April 1, 1994
Summary
Trypanosoma cruzi epimastigotes exhibit unique aerobic glucose fermentation, producing succinate and L-alanine. This metabolic pathway is crucial for energy production and parasite survival in the context of Chagas disease.
Area of Science:
- Biochemistry
- Parasitology
- Molecular Biology
Background:
- Trypanosoma cruzi causes Chagas disease.
- Epimastigotes are a developmental stage of T. cruzi.
- Understanding T. cruzi metabolism is key to developing treatments.
Purpose of the Study:
- To investigate the metabolic pathways of T. cruzi epimastigotes.
- To elucidate the mechanisms behind "aerobic fermentation of glucose" in T. cruzi.
- To identify key enzymes and metabolites involved in glucose and amino acid catabolism.
Main Methods:
- Analysis of glucose and amino acid catabolism.
- Characterization of enzymes like cruzipain, glutamate dehydrogenases, and aminotransferases.
- Metabolite analysis, including succinate, L-alanine, and L-malate.
- Investigation of respiratory chain efficiency and enzyme activities.
Main Results:
- Epimastigotes perform "aerobic fermentation of glucose" producing succinate and L-alanine.
- Low cytochrome levels and lack of NADH dehydrogenase contribute to inefficient NADH reoxidation.
- L-malate is a key metabolite for transporting carbon and reduction equivalents.
- Cruzipain, a cysteine proteinase, is abundant and potentially involved in host-parasite interactions.
- Specific enzymes involved in amino acid catabolism were characterized.
Conclusions:
- The unique "aerobic fermentation of glucose" is a significant metabolic feature of T. cruzi epimastigotes.
- Metabolic enzymes and pathways identified play crucial roles in parasite nutrition, energy production, and potentially host interaction.
- Further research into these pathways could reveal novel therapeutic targets for Chagas disease.